AMINOSALICYLIC ACID - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for aminosalicylic acid and what is the scope of patent protection?

Aminosalicylic acid is the generic ingredient in three branded drugs marketed by Eurocept Pharms, Panray, and Bristol Myers Squibb, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for aminosalicylic acid.

Summary for AMINOSALICYLIC ACID

US Patents:	0
Tradenames:	3
Applicants:	3
NDAs:	3
Drug Master File Entries:	15
Raw Ingredient (Bulk) Api Vendors:	151
Clinical Trials:	28
Patent Applications:	6,610
What excipients (inactive ingredients) are in AMINOSALICYLIC ACID?	AMINOSALICYLIC ACID excipients list
DailyMed Link:	AMINOSALICYLIC ACID at DailyMed

Recent Clinical Trials for AMINOSALICYLIC ACID

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Tanta University	Early Phase 1
Assistance Publique - Hôpitaux de Paris	Phase 1/Phase 2
Sanjay Gandhi Postgraduate Institute of Medical Sciences	Phase 2

See all AMINOSALICYLIC ACID clinical trials

Medical Subject Heading (MeSH) Categories for AMINOSALICYLIC ACID

Antitubercular Agents

US Patents and Regulatory Information for AMINOSALICYLIC ACID

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Eurocept Pharms	PASER	aminosalicylic acid	GRANULE, DELAYED RELEASE;ORAL	074346-001	Jun 30, 1994		RX	No	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Bristol Myers Squibb	REZIPAS	aminosalicylic acid resin complex	POWDER;ORAL	009052-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Panray	PARASAL	aminosalicylic acid	TABLET;ORAL	006811-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.